Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Nonsteroidal anti-inflammatory drugs lower A(beta)42 and change presenilin 1 conformation

Article Abstract:

Reports suggest that some commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) shift the cleavage products of amyloid precursor protein (APP) to shorter, less fibrilogenic forms. A demonstration is presented, using a fluorescence resonance energy transfer method, that A(beta)42-lowering NSAIDs specifically affect the proximity between APP and presenilin 1 and alter persenilin 1 conformation both in vitro and in vivo, suggesting a novel allosteric mechanism of action

Author: Hyman, Bradley T., Frosch, Matthew P., Lleo, Alberto, Herl, Lauren, Deng, Amy, Berezovska, Oksana, Raju, Susan, Bacskai, Brian J., Irizarry, Michael
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2004
Science & research, Health aspects, Nonsteroidal anti-inflammatory drugs, Nonsteroidal anti-inflammatory agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Inflammation and Alzheimer disease: the good, the bad, and the ugly

Article Abstract:

Research presented concerns the role of inflammation in the pathogenesis of Alzheimer's disease, focusing on studies that suggest a therapeutic potential in select aspects of the inflammatory response. Research on AD using a mouse model demonstrates that amyloid beta-protein plaques are decreased through the overexpression of the cytokine TGF-beta 1 by way of the activation of immune cells called microglia.

Author: Yankner, Bruce A., Weninger, Stacie C.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2001
Models, Development and progression, Inflammation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Amyloid beta vaccination: reduced plaques and improved cognition

Article Abstract:

Research presented concerns the treatment of memory loss in Alzheimer disease (AD), focusing on how the amyloid beta-protein may be linked to the development of senile plaques. Research suggests that AD mice immunized with an amyloid beta-peptide fragment have less learning and memory losses, and the potential benefits of this treatment for humans are discussed.

Author: Younkin, Steven G.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2001
Physiological aspects, Memory

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Amyloid beta-protein, Alzheimer's disease
Similar abstracts:
  • Abstracts: Preoperative nonsteroidal anti-inflammatory medication for the prevention of postoperative dental pain. Diabetes and oral health promotion: a survey of disease prevention behaviors
  • Abstracts: Persistent urogenital sinus: prenatal diagnosis and pregnancy complications. The clinical utility of fetal cell sorting to determine prenatally fetal E/e or e/e Rh genotype from peripheral maternal blood
  • Abstracts: Nipping scandals in the bud. And in the poor corner.... This is our problem too
  • Abstracts: A randomized trial of a program of early postpartum discharge with nurse visitation. Maternal asthma and pregnancy outcomes: a retrospective cohort study
  • Abstracts: Prevalence of use of cocaine and other substances in an obstetric population. Case-control study of antenatal cocaine use and platelet levels
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.